Efficacy and safety of mercuric oxide in the treatment of bacterial blepharitis.
AUTOR(ES)
Hyndiuk, R A
RESUMO
A double-masked, placebo-controlled, randomized study was done to assess the safety and clinical and quantitative microbiologic efficacy of 1% mercuric oxide (yellow) ophthalmic ointment in the treatment of eyelid infections, i.e., bacterial blepharitis. A total of 39 patients with bacterial counts and clinical signs indicative of eyelid infection were treated twice daily for 7 days. Clinical biomicroscopic examination and quantitative microbiologic cultures were done just prior to initiation of treatment and again on days 3 and 7. Statistical analysis revealed a significant improvement in the clinical signs, bacterial count, cure rate, and improvement rate for subjects taking the active medication, compared with those taking the placebo on days 3 and 7. In addition, the medication was well tolerated.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=171652Documentos Relacionados
- Comparative bacteriology of chronic blepharitis.
- Penotrane in blepharitis. A double-blind controlled trial.
- Yellow mercuric oxide: a treatment of choice for phthiriasis palpebrarum.
- Safety and efficacy of recombinant gamma interferon in the treatment of systemic sclerosis.
- Efficacy and safety of adenosine in the treatment of supraventricular tachycardia in infants and children.
